LCGC North America
The elution mechanisms for gradient and isocratic HPLC are fundamentally different from each other. Here is what you should understand about both.
The elution mechanism in gradient high- performance liquid chromatography (HPLC) is fundamentally different to that of the isocratic mode. In gradient HPLC, as the elution strength is initially low, analytes may be stationary within the column, partitioned fully into the stationary phase. As the elution strength increases, the analytes begin to migrate through the column with increasing speed, and, depending upon the gradient profile and column length, may be travelling at the same velocity as the mobile (that is, it does not partition into the stationary phase at all) prior to elution. This contrasts with isocratic HPLC, in which the analyte will move with constant speed through the column, as the elution strength of the mobile phase does not change.
While retention behavior in isocratic HPLC is described using the retention factor (k) in gradient HPLC, this is not appropriate, as the retention factor is continuously varying and we must use a new relationship to describe the retention behavior, which is shown in Equation 1:
tg is the gradient time in minutes, F is the eluent flow rate in mL/min, Δφ is the change in eluent composition (i.e. 0.4 for a 20 to 60% B gradient), Vm is the interstitial volume of the column, which is estimated by equation 2:
S is a shape selectivity factor which can be estimated by 0.25 Mw0.5 (for analytes < 1000 Da a value of 5 is typically used for S).
So for the following separation:
k* would be calculated as follows (equation 3):
For a 'good' method, we would ideally want k* to lie in the range 2 to 10, and, for an "acceptable" method, k* should certainly be in the range 1 to 20.
If k* is too low, then we risk interference from other sample components or analytes, as the analyte does not have enough affinity for the stationary phase to differentially partition away from other sample components. When k* is too high, the analysis time is unnecessarily long.
Equation 1 also highlights the important factors which can be easily varied to optimize retention (and therefore selectivity and resolution) in gradient HPLC as the initial and final composition of the gradient (as defined by Δφ), the gradient steepness (as defined by gradient time (tg) assuming Δφ remains unchanged) and the eluent flow rate. The column dimensions can also be altered to effect changes in k*; however, this is much less convenient from a method development perspective.
Of these, it is perhaps most convenient to alter the gradient steepness and we can rearrange equation 1 in a more usable form to allow us to make a prediction of the optimum value of tg for a particular separation as given in equations 4 through 6:
In this way, we can predict the optimum gradient time based on the other parameters within the method. In order to generate an "ideal" k* value of five, in this case a gradient value 12.75 mins would have produced a more ideal separation than the original time of seven minutes.
We may also use another very useful relationship which defines an adjusted gradient steepness (Gs), and which can be used to maintain analyte selectivity when other factors in method are adjusted as in equation 7:
So, for our original example (gradient time of 12.75 mins), if we wanted to change the column dimensions to 100 × 2.1 mm (with a corresponding Vm value of 0.232), by maintaining a constant value for Gs in equation 7, through altering the flow rate or gradient time for example we might expect the chromatogram to be similar in both cases (equations 8 and 9):
By altering the flow rate to 0.6 mL/min (a sensible flow rate for this new column dimension), we can see that a gradient time of 4.4 mins will produce a theoretically equivalent separation.
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.